Prosperity Capital Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$785K Buy
32,587
+2,537
+8% +$66.4K 0.04% 218
2026
Q1
$844K Buy
30,050
+121
+0.4% +$3.22K 0.05% 207
2025
Q4
$745K Buy
29,929
+17,983
+151% +$453K 0.04% 200
2025
Q3
$304K Buy
11,946
+157
+1% +$3.88K 0.02% 347
2025
Q2
$286K Sell
11,789
-505
-4% -$11.8K 0.02% 333
2025
Q1
$302K Buy
12,294
+533
+5% +$13.9K 0.02% 296
2024
Q4
$312K Sell
11,761
-462
-4% -$12.5K 0.03% 275
2024
Q3
$354K Buy
12,223
+2,479
+25% +$72.3K 0.03% 251
2024
Q2
$273K Sell
9,744
-10,179
-51% -$280K 0.03% 251
2024
Q1
$553K Buy
19,923
+9,835
+97% +$273K 0.07% 201
2023
Q4
$290K Sell
10,088
-2,418
-19% -$73.1K 0.03% 201
2023
Q3
$415K Buy
12,506
+3,015
+32% +$107K 0.05% 152
2023
Q2
$348K Sell
9,491
-619
-6% -$24.1K 0.05% 175
2023
Q1
$412K Buy
10,110
+127
+1% +$5.49K 0.06% 135
2022
Q4
$512K Buy
+9,983
New +$479K 0.16% 96

Other funds holding PFE

Prosperity Capital Advisors's PFE Position: Q2 2026 in Review

Prosperity Capital Advisors increased its Pfizer (PFE) stake by 8.4% in Q2 2026, buying an estimated $66.4K and bringing the position to 32,587 shares worth $785K. The position accounts for 0.04% of the portfolio, ranked #218.

Prosperity Capital Advisors first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $844K in Q1 2026. 632 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Prosperity Capital Advisors held 32,587 shares of Pfizer worth $785K as of Q2 2026.
  • Prosperity Capital Advisors bought 2,537 Pfizer shares in Q2 2026, an estimated $66.4K.
  • Pfizer made up 0.04% of Prosperity Capital Advisors's portfolio in Q2 2026, its #218 holding.
  • Prosperity Capital Advisors first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Prosperity Capital Advisors's Pfizer position peaked at $844K in Q1 2026.
  • 632 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Prosperity Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.